Bessemer Group Inc. raised its position in shares of LivaNova PLC (NASDAQ:LIVN) by 625.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,100 shares of the company’s stock after purchasing an additional 22,500 shares during the quarter. Bessemer Group Inc. owned about 0.05% of LivaNova PLC worth $1,829,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Airain ltd bought a new position in LivaNova PLC during the 2nd quarter valued at $1,449,000. Virginia Retirement Systems ET AL bought a new position in LivaNova PLC during the 2nd quarter valued at $2,277,000. Hosking Partners LLP boosted its stake in LivaNova PLC by 1.6% during the 2nd quarter. Hosking Partners LLP now owns 188,518 shares of the company’s stock valued at $11,539,000 after purchasing an additional 3,048 shares in the last quarter. Redmile Group LLC bought a new position in LivaNova PLC during the 2nd quarter valued at $12,978,000. Finally, Russell Investments Group Ltd. bought a new position in LivaNova PLC during the 2nd quarter valued at $957,000. 82.20% of the stock is owned by hedge funds and other institutional investors.
Shares of LivaNova PLC (NASDAQ LIVN) opened at $81.08 on Tuesday. The firm has a market capitalization of $3,869.46, a price-to-earnings ratio of 23.13, a PEG ratio of 2.41 and a beta of 0.52. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03. LivaNova PLC has a one year low of $40.83 and a one year high of $81.85.
LivaNova PLC (NASDAQ:LIVN) last released its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.17. The business had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The company’s revenue was up 4.9% compared to the same quarter last year. During the same period last year, the company posted $0.78 EPS. research analysts anticipate that LivaNova PLC will post 3.33 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “Bessemer Group Inc. Raises Holdings in LivaNova PLC (LIVN)” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://transcriptdaily.com/2017/11/14/bessemer-group-inc-raises-holdings-in-livanova-plc-livn.html.
A number of brokerages have issued reports on LIVN. Piper Jaffray Companies reaffirmed a “buy” rating and set a $85.00 price target on shares of LivaNova PLC in a research note on Friday, November 3rd. Zacks Investment Research raised LivaNova PLC from a “hold” rating to a “buy” rating and set a $89.00 price target for the company in a research note on Thursday, November 9th. BTIG Research reaffirmed a “hold” rating on shares of LivaNova PLC in a research note on Tuesday, November 7th. Jefferies Group LLC increased their price target on LivaNova PLC from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Finally, Needham & Company LLC increased their price target on LivaNova PLC from $83.00 to $89.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. LivaNova PLC currently has an average rating of “Buy” and an average price target of $77.86.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $74.58, for a total transaction of $74,580.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.28% of the company’s stock.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.